JP2023517480A5 - - Google Patents

Info

Publication number
JP2023517480A5
JP2023517480A5 JP2022548034A JP2022548034A JP2023517480A5 JP 2023517480 A5 JP2023517480 A5 JP 2023517480A5 JP 2022548034 A JP2022548034 A JP 2022548034A JP 2022548034 A JP2022548034 A JP 2022548034A JP 2023517480 A5 JP2023517480 A5 JP 2023517480A5
Authority
JP
Japan
Prior art keywords
liquid formulation
peg
formulation according
concentration
rhgm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022548034A
Other languages
English (en)
Japanese (ja)
Other versions
JP7631358B2 (ja
JP2023517480A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/056851 external-priority patent/WO2021185921A1/en
Publication of JP2023517480A publication Critical patent/JP2023517480A/ja
Publication of JP2023517480A5 publication Critical patent/JP2023517480A5/ja
Priority to JP2025017042A priority Critical patent/JP2025090573A/ja
Application granted granted Critical
Publication of JP7631358B2 publication Critical patent/JP7631358B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022548034A 2020-03-17 2021-03-17 吸入のためのｇｍ－ｃｓｆの液体製剤 Active JP7631358B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025017042A JP2025090573A (ja) 2020-03-17 2025-02-04 吸入のためのｇｍ－ｃｓｆの液体製剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062990810P 2020-03-17 2020-03-17
US62/990,810 2020-03-17
EP20164648 2020-03-20
EP20164648.6 2020-03-20
PCT/EP2021/056851 WO2021185921A1 (en) 2020-03-17 2021-03-17 Liquid formulation of gm-csf for inhalation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025017042A Division JP2025090573A (ja) 2020-03-17 2025-02-04 吸入のためのｇｍ－ｃｓｆの液体製剤

Publications (3)

Publication Number Publication Date
JP2023517480A JP2023517480A (ja) 2023-04-26
JP2023517480A5 true JP2023517480A5 (enExample) 2024-03-21
JP7631358B2 JP7631358B2 (ja) 2025-02-18

Family

ID=74871418

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022548034A Active JP7631358B2 (ja) 2020-03-17 2021-03-17 吸入のためのｇｍ－ｃｓｆの液体製剤
JP2025017042A Pending JP2025090573A (ja) 2020-03-17 2025-02-04 吸入のためのｇｍ－ｃｓｆの液体製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025017042A Pending JP2025090573A (ja) 2020-03-17 2025-02-04 吸入のためのｇｍ－ｃｓｆの液体製剤

Country Status (12)

Country Link
US (1) US20230201307A1 (enExample)
EP (1) EP4121000A1 (enExample)
JP (2) JP7631358B2 (enExample)
KR (1) KR102874958B1 (enExample)
CN (1) CN115297844A (enExample)
AU (1) AU2021237761B2 (enExample)
BR (1) BR112022018501A2 (enExample)
CA (1) CA3168421A1 (enExample)
IL (1) IL295406A (enExample)
MX (1) MX2022011498A (enExample)
WO (1) WO2021185921A1 (enExample)
ZA (1) ZA202209002B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120324338A (zh) * 2025-06-10 2025-07-18 厦门特宝生物工程股份有限公司 一种重组人粒细胞巨噬细胞刺激因子注射用液体制剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020141970A1 (en) 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
WO2007009208A1 (en) * 2005-06-02 2007-01-25 Cangene Corporation Poly(ethylene glocol) modified human gm-csf with increased biological activity
CN100394981C (zh) * 2005-09-16 2008-06-18 深圳市孚沃德生物技术有限公司 一种人粒细胞巨噬细胞集落刺激因子喷雾剂及其制备方法
CN1939534B (zh) * 2005-09-27 2010-12-01 长春金赛药业股份有限公司 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
RU2446173C1 (ru) * 2010-08-13 2012-03-27 Зао "Биокад" Новый функционально активный, высокоочищенный стабильный конъюгат гранулоцитарного колониестимулирующего фактора (г-ксф) с полиэтиленгликолем с пролонгированным биологическим действием, пригодный для медицинского применения, и иммунобиологическое средство на его основе
WO2020002650A1 (en) * 2018-06-29 2020-01-02 Targovax Asa A formulation

Similar Documents

Publication Publication Date Title
US20250000821A1 (en) Methods of using dipivefrin
BG108457A (bg) Метод и комплект за увеличаване обема на косата
US20080112896A1 (en) Therapeutic Compositions for Pulmonary Delivery
WO2008025560A1 (en) Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
JP2774379B2 (ja) 医薬エアロゾール組成物ならびにそれらのウイルス疾患の治療および予防用途
Arthur et al. Novel modes of antifungal drug administration
EP2098219A1 (en) Macrolide compositions having improved taste and stability
AU2011268101A1 (en) Novel formulation of pegylated-liposome encapsulated glycopeptide antibiotics
ES3028423T3 (en) Norketotifen for use in the treatment of respiratory disorders
CN101801346A (zh) 抗失眠症组合物及方法
US20250387468A1 (en) Methods and Compositions for Treating Infections
CN114533706B (zh) 一种用于防治呼吸道疾病的雾化吸入制剂及其应用
JP2023517480A5 (enExample)
JP2023518269A5 (enExample)
JP2008508265A5 (enExample)
JP2025090573A (ja) 吸入のためのｇｍ－ｃｓｆの液体製剤
NZ791835B2 (en) Liquid formulation of gm-csf for inhalation
CN115867288A (zh) 用于治疗呼吸系统病症的组合物
CN114632075B (zh) 一种伏立康唑雾化吸入剂和用途
RU2728938C1 (ru) Применение даларгина для производства лекарственных средств профилактики пневмонии
EA049666B1 (ru) Жидкий состав gm-csf для ингаляции
Onoue et al. Inhaled Biologics: Overcoming Challenges and Recent Advances
EP4699604A1 (en) Inhaled adenovirus vector vaccine, preparation method therefor and use thereof
CN120549858A (zh) 重组人干扰素α1b溶液及其制备方法与应用
CN121445880A (zh) 一种促进药物吸收的组合物及其应用